Genetic and biological subgroups of low-stage follicular thyroid cancer
about
Mutation Profile of Well-Differentiated Thyroid Cancer in AsiansPax-8-PPAR-γ fusion protein in thyroid carcinomaThyroid cancer: current molecular perspectives.The role of the PAX8/PPARgamma fusion oncogene in the pathogenesis of follicular thyroid cancerMolecular diagnostics of fine needle aspiration for the presurgical screening of thyroid nodules.Lessons from mouse models of thyroid cancer.Multi-targeted approach in the treatment of thyroid cancer.PAX8/PPARγ rearrangement in thyroid nodules predicts follicular-pattern carcinomas, in particular the encapsulated follicular variant of papillary carcinoma.Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patternsMolecular approaches to thyroid cancer diagnosis.The Putative PAX8/PPARγ Fusion Oncoprotein Exhibits Partial Tumor Suppressor Activity through Up-Regulation of Micro-RNA-122 and Dominant-Negative PPARγ ActivityUnusual thyroid tumors: a review of pathologic and molecular diagnosis.Modeling thyroid cancer in the mouse.Peroxisome proliferator-activated receptor-delta induces cell proliferation by a cyclin E1-dependent mechanism and is up-regulated in thyroid tumorsMolecular biology of thyroid cancer initiation.Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis.Thyroid carcinoma: molecular pathways and therapeutic targetsOncocytic mania: a review of oncocytic lesions throughout the body.New treatments and shifting paradigms in differentiated thyroid cancer management.Cytologic and molecular diagnosis of thyroid cancers: is it time for routine reflex testing?The quest for diagnostic molecular markers for thyroid nodules with indeterminate or suspicious cytology.RET/PTC rearrangement is prevalent in follicular Hürthle cell carcinomas.Promise and pitfalls of molecular markers of thyroid nodules.Genetics and epigenetics of sporadic thyroid cancer.Follicular thyroid tumors with the PAX8-PPARgamma1 rearrangement display characteristic genetic alterations.Expression profiling reveals a distinct transcription signature in follicular thyroid carcinomas with a PAX8-PPAR(gamma) fusion oncogene.Expression of the PAX8/PPARγ Fusion Protein Is Associated with Decreased Neovascularization In Vivo: Impact on Tumorigenesis and Disease Prognosis.Molecular genetics of thyroid cancer.HMGA2 gene expression analysis performed on cytologic smears to distinguish benign from malignant thyroid nodules.PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription.Underexpression of peroxisome proliferator-activated receptor (PPAR)gamma in PAX8/PPARgamma-negative thyroid tumours.The Role of the PAX8/PPARgamma Fusion Oncogene in Thyroid Cancer.Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors.[Nodule diagnosed as follicular patterned lesion: are biomarkers the promise?].Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas.Follicular cell-derived thyroid cancer.Novel targeted therapies and immunotherapy for advanced thyroid cancers.Diagnostic and prognostic implications of the PAX8-PPARγ translocation in thyroid carcinomas-a TMA-based study of 226 cases.Aneuploidy and RAS mutations are mutually exclusive events in the development of well-differentiated thyroid follicular tumours.Pathogenesis of differentiated thyroid cancer (papillary and follicular)
P2860
Q26782322-E774585B-22D8-4EEC-9B8D-E76C6D52AD08Q28244806-9723FFCC-D910-4409-9EC5-BEC0C5AC4CD9Q33760910-067EA5BA-5235-4375-A120-4BF12F287FEFQ33770842-592079F2-55C8-46CE-A86A-1C3AA7BED0DDQ33782114-7CDDB18D-9284-4221-9BDC-4AE689370A35Q33819911-8B8EF2F0-DC7C-4444-AA1F-C6F6870ED242Q33982413-5A1183DD-D0A0-44A9-9982-8D095FD78311Q34103817-EDC88336-6AAC-4A29-9AE1-7BE707B532F6Q34119294-0025A063-F790-470A-8B39-23960CCBC415Q34160828-1B962565-EBF1-40EE-AD1B-4406D4211048Q35034073-FA74B81F-97CF-414F-84D7-50D3C92E6EB7Q36252185-D7A4FD68-4D46-46C4-BC80-72AA141497C7Q36297044-FAE4E4B6-3FAA-4C24-ADA2-D8E80EF372D5Q36983141-77FC6D8E-A459-42F1-B53B-2E6A8673D31FQ37022649-E29609CF-D15B-4770-A257-D985B2950ADEQ37035285-67DE2836-4DB9-4C29-A553-1F3EABB99BD0Q37147768-D29B0707-EC4F-482E-BEA7-5C647CB9BB3DQ37837353-5A325B07-BF35-4179-996C-26599F3EF296Q37859611-EE7A79BD-574E-4C3D-883B-6D5CAA041800Q37924711-108305D8-5258-4027-B1CC-E7C2CEE4F12AQ37996353-906A8D66-2B46-4275-85F7-72AB3646900FQ38026893-9D1B86CC-2C32-43AD-B9A3-4E57DF28C6A2Q38097037-144A022B-003D-4099-8246-420E385580C7Q38128097-27605CD1-3ED3-47A0-AC03-A4B2BCAF092CQ38324581-69AD9BAE-DC66-464B-ABC4-F2187AF94B03Q38332874-F69AFB9B-673D-4360-BAB7-FE388ABFCB79Q38414822-DD2C5BFF-9270-45A1-B875-9CF2D03F4123Q38833275-32EE5D83-23DA-42F6-8CDE-505916652DD2Q39685650-79894FBE-8823-4024-B175-5023E77A38DCQ39896091-87898406-0819-4081-9760-CD5A16333292Q41894503-E1A3A9E6-D201-4697-BE96-FBBB1D3B5A9EQ42023771-5EC14117-398E-4987-B35E-9E4C049F88FEQ43885509-3DDA1123-BEF9-4378-9AEC-B3B7ACE2DC58Q46985000-81CADC57-5661-4A97-B2DB-1CBA9A0CAA05Q47250251-942352CA-9B65-4563-AE7F-0DC8880D9B9EQ48651339-5CA9A16F-7591-4A68-A846-CA40C336F398Q49887965-1EBCD2EF-A518-4A6E-AF62-1D8730E3997AQ50935451-3AEE01BB-3E91-416C-B8B6-9613FB55407BQ51909840-2E147067-1E11-4A1B-8514-3FB6990D2B91Q56568567-970B662D-9513-439D-8130-195690BCB087
P2860
Genetic and biological subgroups of low-stage follicular thyroid cancer
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Genetic and biological subgroups of low-stage follicular thyroid cancer
@ast
Genetic and biological subgroups of low-stage follicular thyroid cancer
@en
type
label
Genetic and biological subgroups of low-stage follicular thyroid cancer
@ast
Genetic and biological subgroups of low-stage follicular thyroid cancer
@en
prefLabel
Genetic and biological subgroups of low-stage follicular thyroid cancer
@ast
Genetic and biological subgroups of low-stage follicular thyroid cancer
@en
P2093
P2860
P1476
Genetic and biological subgroups of low-stage follicular thyroid cancer
@en
P2093
Christopher A French
Edmund S Cibas
Erik K Alexander
Francis Moore
Jeff Garber
Jonathan A Fletcher
Julia Laguette
P Reed Larsen
Todd G Kroll
Vania Nose
P2860
P304
P356
10.1016/S0002-9440(10)63902-8
P407
P577
2003-04-01T00:00:00Z